In their prepared statement the generic industry mentioned that many of the investments by brand name drug companies are today directed to countries like Brazil, Russia, India, and China, which are not known for having strong intellectual property regimes. Why do you think we need that when currently development is going to countries that don't have it?
That was for Ms. Garland again.